$9.38 Million in Sales Expected for Alcentra Capital Corp. (NASDAQ:ABDC) This Quarter

Wall Street analysts expect Alcentra Capital Corp. (NASDAQ:ABDC) to announce $9.38 million in sales for the current quarter, according to Zacks. Six analysts have issued estimates for Alcentra Capital Corp.’s earnings, with estimates ranging from $9.16 million to $9.67 million. Alcentra Capital Corp. reported sales of $10.64 million during the same quarter last year, which would suggest a negative year over year growth rate of 11.8%. The firm is expected to report its next quarterly earnings report on Thursday, August 3rd.

According to Zacks, analysts expect that Alcentra Capital Corp. will report full year sales of $9.38 million for the current financial year, with estimates ranging from $36.87 million to $38.66 million. For the next financial year, analysts anticipate that the firm will post sales of $42.00 million per share, with estimates ranging from $39.50 million to $43.82 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for Alcentra Capital Corp..

A number of equities analysts have weighed in on the stock. DA Davidson assumed coverage on shares of Alcentra Capital Corp. in a research report on Wednesday, July 5th. They issued a “buy” rating and a $15.00 price objective for the company. Raymond James Financial, Inc. cut shares of Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and decreased their price objective for the company from $16.00 to $14.00 in a research report on Monday, July 17th. TheStreet raised shares of Alcentra Capital Corp. from a “c” rating to a “b-” rating in a research report on Monday, April 3rd. Finally, Keefe, Bruyette & Woods set a $14.00 price objective on shares of Alcentra Capital Corp. and gave the company a “hold” rating in a research report on Wednesday, May 31st. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Alcentra Capital Corp. has an average rating of “Hold” and a consensus price target of $13.75.

In other news, major shareholder Of New York Mellon Corp Bank sold 1,691,839 shares of the stock in a transaction dated Monday, May 22nd. The shares were sold at an average price of $13.13, for a total transaction of $22,213,846.07. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 4.96% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. Salzhauer Michael boosted its position in shares of Alcentra Capital Corp. by 62.6% in the second quarter. Salzhauer Michael now owns 47,292 shares of the asset manager’s stock valued at $643,000 after buying an additional 18,200 shares during the last quarter. Bank of Montreal Can bought a new position in shares of Alcentra Capital Corp. during the second quarter valued at approximately $163,000. Confluence Investment Management LLC boosted its position in shares of Alcentra Capital Corp. by 2.7% in the second quarter. Confluence Investment Management LLC now owns 209,528 shares of the asset manager’s stock valued at $2,847,000 after buying an additional 5,566 shares during the last quarter. UBS Group AG boosted its position in shares of Alcentra Capital Corp. by 20.7% in the first quarter. UBS Group AG now owns 258,940 shares of the asset manager’s stock valued at $3,558,000 after buying an additional 44,387 shares during the last quarter. Finally, Ares Management LLC boosted its position in shares of Alcentra Capital Corp. by 3.5% in the first quarter. Ares Management LLC now owns 434,049 shares of the asset manager’s stock valued at $5,964,000 after buying an additional 14,525 shares during the last quarter. 43.59% of the stock is currently owned by institutional investors and hedge funds.

Shares of Alcentra Capital Corp. (ABDC) opened at 12.49 on Friday. The firm’s 50-day moving average price is $13.28 and its 200-day moving average price is $13.24. Alcentra Capital Corp. has a one year low of $11.17 and a one year high of $14.73.

The business also recently declared a quarterly dividend, which was paid on Thursday, July 6th. Stockholders of record on Friday, June 30th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Wednesday, June 28th. This represents a $1.36 annualized dividend and a dividend yield of 10.89%. Alcentra Capital Corp.’s payout ratio is 340.00%.

TRADEMARK VIOLATION WARNING: This report was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this report on another site, it was illegally stolen and republished in violation of United States and international copyright laws. The original version of this report can be read at https://stocknewstimes.com/2017/08/02/9-38-million-in-sales-expected-for-alcentra-capital-corp-nasdaqabdc-this-quarter-updated.html.

Alcentra Capital Corp. Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Get a free copy of the Zacks research report on Alcentra Capital Corp. (ABDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Alcentra Capital Corp. (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply